Alzheimer’s disease and the β-amyloid peptide : Aβ conformers and mechanisms of spreading
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
In: Proc Natl Acad Sci USA 2017b; 114: 13018-13023. (doi:10.1073/pnas.1713215114)
Tübingen, Universität Tübingen, Dissertation, 2020
- Schlagwort
-
Amyloid
Alzheimerkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Tübingen
- (wer)
-
Universitätsbibliothek Tübingen
- (wann)
-
2022
- Urheber
- Beteiligte Personen und Organisationen
-
Jucker, Mathias
- URN
-
urn:nbn:de:bsz:21-dspace-1008502
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Beschorner, Natalie
- Jucker, Mathias
- Universitätsbibliothek Tübingen
Entstanden
- 2022
Ähnliche Objekte (12)
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Abeta Peptide and Alzheimer's Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Studie zur Rolle N-trunkierter Amyloid-β-Peptide bei der Alzheimer-Krankheit
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Abeta Peptide and Alzheimer's Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis
Studie zur Rolle N-trunkierter Amyloid-β-Peptide bei der Alzheimer-Krankheit
Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
Structural Characterization of Interactions between the Alzheimer’s Disease Amyloid-Beta Peptide and Small Molecules and Peptide Inhibitors
Abeta Peptide and Alzheimer's Disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
The interaction between the neural cell adhesion molecule L1 and β-amyloid peptide : potential relevance in Alzheimer’s disease
Mechanisms of pathogenic tau and A[Beta] protein spreading in Alzheimer’s disease
Alzheimer’s disease: Amyloid oligomers, therapeutic agents, their target and mode of action
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Cellular mechanism of amyloid formation in Alzheimer’s disease and systemic AA amyloidosis